Search
Home
News
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Coins2Day 500
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Pharmaceutical Industry
Pharmaceutical Industry
Health
GLP-1s could end up being ‘the first true longevity drug’ as the world battles a rising obesity crisis
By
Industry Analyst
November 21, 2025
Newsletters
Why big pharma is teaming up with AI giants to speed up drug discovery and make work easier for health care workers
By
Industry Analyst
November 19, 2025
Economy
Novo Nordisk CFO outlines ‘ultimate defense’ against stock downgrades and lawsuits to retain weight-loss crown
By
Contributing Writer
November 6, 2025
Workplace Culture
How pharma giant AbbVie holds leaders accountable for culture
By
Ted Kitterman
and
Great Place To Work
October 9, 2025
North America
Mark Cuban says Trump’s new drug platform could succeed if it forces pharma managers to change: ‘If that happens, Trump gets all the credit’
By
Contributing Writer
October 2, 2025
Success
Mark Cuban says his best investment of all time was still living like a student after college—including sleeping on the floor and driving a $200 broken car
By
Editorial Team
September 29, 2025
Economy
All bark, no bite: Trump’s latest trade war turns into another TACO salad for Wall Street
By
Research Team
September 26, 2025
Investing
Trump’s overnight demand for 100% tariffs on pharmaceuticals will be ‘a meaningful commercial hit for U.S. consumers,’ top analyst says
By
Financial Writer
September 26, 2025
Health
Scientists rebuke Trump’s Tylenol-autism claim, stress fever is bigger danger in pregnancy
By
Jason Gale
and
Bloomberg
September 23, 2025
North America
Swiss drug giant looks for ways to lower U.S. prices amid tariff threat and admits Americans ‘pay for a large part of the innovations’
By
Senior Editor
September 20, 2025
Innovation
The AI drug breakthrough is taking a long time to arrive for reasons that may have little to do with the technology’s limits
By
Blockchain Reporter
September 12, 2025
Commentary
A new era of access demands smarter design for direct-to-consumer drug pricing
By
Senior Editor
September 5, 2025
Commentary
AI might beat IQ, not EQ — but never say never
By
Senior Editor
September 2, 2025
Politics
Trump’s plan for hefty tax on imported drugs risks higher prices and shortages
By
Paul Wiseman
,
Tom Murphy
and
The Associated Press
September 1, 2025
Health
Novo Nordisk slashes price of Ozempic in half to $499 for cash-paying, eligible U.S. patients
By
Editorial Team
August 18, 2025
Most Popular
AI
Elon Musk says that in 10 to 20 years, work will be optional and money will be irrelevant thanks to AI and robotics
By
News Correspondent
Economy
One of the world’s most popular economists on why AI is ‘undoubtedly going to crash’: It’s built off ‘digital...
By
Industry Analyst
Economy
Trump's retreats on tariffs have already wiped out $800 billion of expected deficit reduction, CBO estimates
By
Industry Analyst